NasdaqGS - Nasdaq Real Time Price USD

Definitive Healthcare Corp. (DH)

5.14 -0.21 (-4.02%)
As of 1:13 PM EDT. Market Open.
Loading Chart for DH
DELL
  • Previous Close 5.35
  • Open 5.33
  • Bid 5.09 x 100
  • Ask 5.17 x 100
  • Day's Range 5.10 - 5.44
  • 52 Week Range 4.38 - 12.45
  • Volume 1,456,891
  • Avg. Volume 575,290
  • Market Cap (intraday) 605.596M
  • Beta (5Y Monthly) 1.41
  • PE Ratio (TTM) --
  • EPS (TTM) -1.76
  • Earnings Date May 7, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.85

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

www.definitivehc.com

950

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DH

Performance Overview: DH

Trailing total returns as of 5/9/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

DH
48.34%
S&P 500
9.20%

1-Year Return

DH
49.01%
S&P 500
25.87%

3-Year Return

DH
--
S&P 500
16.25%

5-Year Return

DH
--
S&P 500
16.25%

Compare To: DH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DH

Valuation Measures

Annual
As of 5/8/2024
  • Market Cap

    630.95M

  • Enterprise Value

    599.80M

  • Trailing P/E

    --

  • Forward P/E

    14.08

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.41

  • Price/Book (mrq)

    0.73

  • Enterprise Value/Revenue

    2.35

  • Enterprise Value/EBITDA

    -2.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -78.16%

  • Return on Assets (ttm)

    -0.92%

  • Return on Equity (ttm)

    -21.54%

  • Revenue (ttm)

    255.69M

  • Net Income Avi to Common (ttm)

    -199.84M

  • Diluted EPS (ttm)

    -1.76

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    295.17M

  • Total Debt/Equity (mrq)

    22.09%

  • Levered Free Cash Flow (ttm)

    90.45M

Research Analysis: DH

Company Insights: DH

Research Reports: DH

People Also Watch